Lite Strategy, Inc.
Lite Strategy, Inc. (Nasdaq: LITS) is a pharmaceutical company and digital-asset treasury company. Its pharmaceutical work centers on preclinical development of drug candidates, evaluated alone or with standard treatments, with the aim of addressing medical needs and creating opportunities for partnerships, licensing… From the company’s description.
In fiscal 2026, Lite Strategy, Inc. reported a net loss of $71.15M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Lite Strategy, Inc. does
In the company’s own words
Lite Strategy, Inc. (Nasdaq: LITS) is a pharmaceutical company and digital-asset treasury company. Its pharmaceutical work centers on preclinical development of drug candidates, evaluated alone or with standard treatments, with the aim of addressing medical needs and creating opportunities for partnerships, licensing or sale. Its pipeline includes voruciclib, an oral CDK9 inhibitor being evaluated for nononcologic diseases, and zandelisib, an oral selective PI3Kδ inhibitor for which the company is assessing licensing or sale opportunities. The company also holds Litecoin (LTC) as a primary reserve asset and uses covered call options on some holdings as part of its treasury management. It began this strategy in 2025 after raising $100 million in a private investment in public equity. In 2024, it sold ME-344, a mitochondrial inhibitor, to Aardvark Therapeutics for development in obesity and metabolic diseases; the deal includes potential milestone payments. The company reports pharmaceutical research and development alongside its Litecoin treasury activities.
Company details
- Sector
- Financials
- Industry (SIC)
- Finance Services
- Headquarters
- SAN DIEGO, CA
- Fiscal year end
- June
- CIK
- 1262104
- SIC
- 6199
Financial performance, year by year
Fiscal 2012–2026 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Lite Strategy, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Lite Strategy, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Lite Strategy, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Lite Strategy, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Lite Strategy, Inc.'s last four quarterly filings that the numbers alone won't show?”